National Health (Pharmaceutical Benefits) Legislation Amendment (Continuing Treatment during Coronavirus Pandemic) Instrument 2020 (PB 32 of 2020)
Administered by
- Department of Health and Aged Care
This item is authorised by the following title:
Australian Government